A Johnson & Johnson unit working to resolve massive cancer litigation in bankruptcy court was accused by a former head of the ...
10h
Hosted on MSNRegeneron makes second bid for blood cancer therapy approvalThe FDA will issue a decision on odronextamab’s accelerated approval in relapsed/refractory follicular lymphoma by 30 July ...
Hi, I’m Dr. Robin Miller for HealthDay.PFAS, also known as forever chemicals, are in the blood of nearly all Americans. We’re exposed to them when we use certai ...
A blood test developed at the University of New England could help more women survive one of the most aggressive forms of ...
The American people have consistently supported life-saving cancer research. Now the nation’s bedrock source of public ...
Artificial intelligence improves process control and reduces the time required to produce key products such as the COVID-19 ...
Oak Cliff Beverage Works (OCBW), a Texas-based company, has voluntarily recalled over 16,000 units of its Beverage Base Lemonade.
The Trump administration has for weeks been blocking the U.S. National Institutes of Health process for issuing new research ...
A lemonade brand sold nationwide has been recalled after its chemicals were found to be linked to cancer. Regulators found it ...
An expert explained a potential side effect associated with treatment consisting of Itovebi for breast cancer.
We maintain our fair value estimate of $187 per share. Xywav (for excessive daytime sleepiness), Epidiolex (for childhood epilepsy), and Rylaze (for leukemia) have continued to be Jazz’s primary ...
The FDA accepted a supplemental biologics license application for Opdivo plus Yervoy as a first-line treatment for some adult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results